StockMacro
Menu

InfuSystem

$14.35 +51% in 6 monthsMarket cap $287.5M

INFU on XASE, Health Care, InfuSystem Holdings, Inc., job postings

Measures activity, not value. Not investment advice.

Profit jumped 71% to $9.4M over 12 months while revenue grew only 2.4%.

  • GoodInstitutional holders rose 16% to 116 filers in one quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
473
Website
infusystem.com
Listed
NYSE American, US
Last results
5 Nov 2026
Next results
expected around 23 Feb 2027 (an estimate: a year ago it reported on 24 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $37.6M, net income $3.2M.
Quarter to 31 Dec 2021: revenue $26.5M, net income $387KQuarter to 31 Dec 2021: revenue $26.5M, net income $387KQuarter to 31 Mar 2022: revenue $26.8M, net income -$368KQuarter to 31 Mar 2022: revenue $26.8M, net income -$368KQuarter to 30 Jun 2022: revenue $27.0M, net income -$164KQuarter to 30 Jun 2022: revenue $27.0M, net income -$164KQuarter to 30 Sep 2022: revenue $27.3M, net income $443KQuarter to 30 Sep 2022: revenue $27.3M, net income $443KQuarter to 31 Dec 2022: revenue $28.8M, net income $107KQuarter to 31 Dec 2022: revenue $28.8M, net income $107KQuarter to 31 Mar 2023: revenue $30.4M, net income -$324KQuarter to 31 Mar 2023: revenue $30.4M, net income -$324KQuarter to 30 Jun 2023: revenue $31.7M, net income $435KQuarter to 30 Jun 2023: revenue $31.7M, net income $435KQuarter to 30 Sep 2023: revenue $31.9M, net income $689KQuarter to 30 Sep 2023: revenue $31.9M, net income $689KQuarter to 31 Dec 2023: revenue $31.8M, net income $72KQuarter to 31 Dec 2023: revenue $31.8M, net income $72KQuarter to 31 Mar 2024: revenue $32.0M, net income -$1.1MQuarter to 31 Mar 2024: revenue $32.0M, net income -$1.1MQuarter to 30 Jun 2024: revenue $33.7M, net income $717KQuarter to 30 Jun 2024: revenue $33.7M, net income $717KQuarter to 30 Sep 2024: revenue $35.3M, net income $1.8MQuarter to 30 Sep 2024: revenue $35.3M, net income $1.8MQuarter to 31 Dec 2024: revenue $33.8M, net income $933KQuarter to 31 Dec 2024: revenue $33.8M, net income $933KQuarter to 31 Mar 2025: revenue $34.7M, net income -$267KQuarter to 31 Mar 2025: revenue $34.7M, net income -$267KQuarter to 30 Jun 2025: revenue $36.0M, net income $2.6MQuarter to 30 Jun 2025: revenue $36.0M, net income $2.6MQuarter to 30 Sep 2025: revenue $36.5M, net income $2.3MQuarter to 30 Sep 2025: revenue $36.5M, net income $2.3MQuarter to 31 Dec 2025: revenue $36.2M, net income $2.0MQuarter to 31 Dec 2025: revenue $36.2M, net income $2.0MQuarter to 31 Mar 2026: revenue $33.7M, net income $1.0MQuarter to 31 Mar 2026: revenue $33.7M, net income $1.0MQuarter to 30 Jun 2026: revenue $36.9M, net income $3.2MQuarter to 30 Jun 2026: revenue $36.9M, net income $3.2MQuarter to 30 Sep 2026: revenue $37.6M, net income $3.2MQuarter to 30 Sep 2026: revenue $37.6M, net income $3.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $37.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$37.6M$3.2M
30 Jun 2026$36.9M$3.2M
31 Mar 2026$33.7M$1.0M
31 Dec 2025$36.2M$2.0M
30 Sep 2025$36.5M$2.3M
30 Jun 2025$36.0M$2.6M
31 Mar 2025$34.7M-$267K
31 Dec 2024$33.8M$933K
30 Sep 2024$35.3M$1.8M
30 Jun 2024$33.7M$717K
31 Mar 2024$32.0M-$1.1M
31 Dec 2023$31.8M$72K
30 Sep 2023$31.9M$689K
30 Jun 2023$31.7M$435K
31 Mar 2023$30.4M-$324K
31 Dec 2022$28.8M$107K
30 Sep 2022$27.3M$443K
30 Jun 2022$27.0M-$164K
31 Mar 2022$26.8M-$368K
31 Dec 2021$26.5M$387K
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $144.4M $141.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +2.4% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $9.4M $5.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.44 $0.26
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 57.6% 55.4% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 9.8% 7.7% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 6.5% 3.9% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 15.8% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $24.8M $24.3M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $9.1M $955K
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $19.7M $20.9M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $10.6M $20.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.31 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.20
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 30.5 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.0 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.1 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 4.5 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
InfuSystemINFU (this company) $287.5M30.52.0+2.4%6.5%
Treace Medical ConceptsTMCI $282.6Mloss1.4-7.1%-27.4%
NeuropaceNPCE $273.9Mloss2.9+8.9%-20.0%
SS Innovations InternationalSSII $254.9Mloss5.5+27%-31.5%
Orthofix MedicalOFIX $247.4Mloss0.30+2.1%-5.4%
EmbectaEMBC $341.1M3.90.33-7.6%8.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+16%

116 13F filers vs 100

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

77%

15.5M shares held by 13F filers (30 Sep 2026) of 20.0M outstanding (8 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.4%

683K shares sold short (30 Oct 2026) of 20.0M outstanding (8 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.7

683K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-16%

813K shares sold short in the report before, 683K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

55%

55% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.0%

$37.6M vs $36.5M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$64K

the 12 months before: $95K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

3

3 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

3 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 813K, 5.6× a year earlier

Price $14.35 on 20 Nov 2026, +56% over 12 months (12-month range $7.42 to $15.28)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $150K in the last 12 months (the 12 months before: $21K).
Revenue per quarter. Revenue $37.6M in the latest quarter, +3.0% on a year earlier.
Capital spending per quarter. Capital spending $73K in the latest quarter, -7.6% on a year earlier.
Institutional holders (13F filers). 116 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.
Federal obligations. Federal obligations: $51K published in the last 12 months, -46% on the 12 months before.
Lobbying spend. Lobbying spend: $0 published in the last 12 months.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 683K vs usual 190K (2026-10-30); 4.5x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 813K vs usual 179K (2026-10-15); 5.6x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 864K vs usual 179K (2026-09-30); 3.5x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 812K vs usual 172K (2026-09-15); 5.7x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 755K vs usual 169K (2026-08-31); 4.6x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 734K vs usual 165K (2026-08-14); 4.6x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 781K vs usual 162K (2026-07-31); 5.5x the same period a year earlier
14 May 20268-K and other filingsDirector or officer change
13 May 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 131K)
12 May 20268-K and other filingsDirector or officer change
12 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Mar 20268-K and other filingsChanged its auditor
1 Jul 2025Sharp changeShort interest spike: short interest spike, 606K vs usual 171K (2025-06-13); 4.3x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 508K vs usual 170K (2025-05-30); 3.6x the same period a year earlier
3 Jun 20258-K and other filingsDirector or officer change
20 May 20258-K and other filingsDirector or officer change
1 Apr 20258-K and other filingsDirector or officer change
1 Apr 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Nov 20248-K and other filingsDirector or officer change
18 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 May 2024Sharp changeClustered insider buying: clustered insider buying (6 independent filers, 6 filing(s) in 30 days, value_usd total 123K)
3 Apr 20248-K and other filingsDelisting notice or listing transfer
14 Mar 20248-K and other filingsReport will be filed late
8 Mar 20248-K and other filingsDirector or officer change
8 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Jul 20238-K and other filingsChanged its auditor
24 May 20238-K and other filingsDirector or officer change
28 Mar 20238-K and other filingsDirector or officer change
28 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Oct 2022Lobbying filinglobbying engagement terminated (TIBER CREEK GROUP)
23 Sep 20228-K and other filingsDirector or officer change
23 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Jun 2022Sharp changeShort interest spike: short interest spike, 739K vs usual 258K (2022-06-15); 3.1x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 786K vs usual 252K (2022-05-31); 3.4x the same period a year earlier
31 May 2022Sharp changeShort interest spike: short interest spike, 749K vs usual 246K (2022-05-13); 3.4x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 644K vs usual 240K (2022-04-29); 2.7x the same period a year earlier
Insider net buying (open market)
Month from 1 Nov 2021: -$1.6M published
Month from 1 Dec 2021: -$163K published
Month from 1 Jan 2022: -$1.0M published
Month from 1 Feb 2022: $107K published
Month from 1 Mar 2022: -$215K published
Month from 1 May 2022: -$86K published
Month from 1 Jun 2022: -$413K published
Month from 1 Sep 2022: -$215K published
Month from 1 Nov 2022: -$834K published
Month from 1 Dec 2022: -$218K published
Month from 1 Mar 2023: $64K published
Month from 1 Jun 2023: -$511K published
Month from 1 Aug 2023: -$1.1M published
Month from 1 Sep 2023: -$409K published
Month from 1 May 2024: $123K published
Month from 1 Sep 2024: $24K published
Month from 1 Nov 2024: -$364K published
Month from 1 May 2025: $77K published
Month from 1 Aug 2025: -$56K published
Month from 1 Mar 2026: $19K published
Month from 1 May 2026: $131K published
Revenue per quarter
Quarter ended 31 Dec 2021: $26.5M, +7.3% on a year earlier; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $26.8M, +9.4% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $27.0M, +8.9% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $27.3M, +2.7% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $28.8M, +8.7% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $30.4M, +13% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $31.7M, +17% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $31.9M, +17% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $31.8M, +10% on a year earlier; public on 11 Apr 2024
Quarter ended 31 Mar 2024: $32.0M, +5.4% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $33.7M, +6.2% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $35.3M, +11% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $33.8M, +6.5% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $34.7M, +8.5% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $36.0M, +6.8% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $36.5M, +3.3% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $36.2M, +7.0% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $33.7M, -3.0% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $36.9M, +2.6% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $37.6M, +3.0% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $373K, +63% on a year earlier; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $178K, +29% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $158K, -19% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $235K, -14% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $411K, +10% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $317K, +78% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $177K, +12% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $122K, -48% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $408K, -0.7% on a year earlier; public on 11 Apr 2024
Quarter ended 31 Mar 2024: $182K, -43% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $337K, +90% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $43K, -65% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $530K, +30% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $131K, -28% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $217K, -36% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $79K, +84% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $133K, -75% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $157K, +20% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $91K, -58% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $73K, -7.6% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 74; public on 14 Feb 2022
31 Mar 2022 report: 76; public on 16 May 2022
30 Jun 2022 report: 66; public on 15 Aug 2022
30 Sep 2022 report: 58; public on 14 Nov 2022
31 Dec 2022 report: 63; public on 14 Feb 2023
31 Mar 2023 report: 60; public on 15 May 2023
30 Jun 2023 report: 60; public on 14 Aug 2023
30 Sep 2023 report: 63; public on 14 Nov 2023
31 Dec 2023 report: 57; public on 14 Feb 2024
31 Mar 2024 report: 64; public on 15 May 2024
30 Jun 2024 report: 74; public on 14 Aug 2024
30 Sep 2024 report: 76; public on 14 Nov 2024
31 Dec 2024 report: 85; public on 14 Feb 2025
31 Mar 2025 report: 92; public on 15 May 2025
30 Jun 2025 report: 89; public on 14 Aug 2025
30 Sep 2025 report: 93; public on 14 Nov 2025
31 Dec 2025 report: 98; public on 17 Feb 2026
31 Mar 2026 report: 95; public on 15 May 2026
30 Jun 2026 report: 100; public on 14 Aug 2026
30 Sep 2026 report: 116; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $4K published
Month from 1 Jan 2022: $3K published
Month from 1 Feb 2022: $5K published
Month from 1 Mar 2022: -$357 published
Month from 1 May 2022: $96K published
Month from 1 Jul 2022: $30K published
Month from 1 Aug 2022: $2K published
Month from 1 Sep 2022: -$95 published
Month from 1 Oct 2022: $34K published
Month from 1 Nov 2022: -$5K published
Month from 1 Dec 2022: $19K published
Month from 1 Jan 2023: -$1K published
Month from 1 Mar 2023: $25K published
Month from 1 Apr 2023: $25K published
Month from 1 Aug 2023: $4K published
Month from 1 Sep 2023: $24K published
Month from 1 Oct 2023: $30K published
Month from 1 Nov 2023: -$12K published
Month from 1 Dec 2023: $2K published
Month from 1 Jan 2024: $3K published
Month from 1 Feb 2024: $2K published
Month from 1 Mar 2024: $30K published
Month from 1 Apr 2024: $26K published
Month from 1 May 2024: $8K published
Month from 1 Jul 2024: $856 published
Month from 1 Aug 2024: $2K published
Month from 1 Sep 2024: -$2K published
Month from 1 Oct 2024: $42K published
Month from 1 Nov 2024: -$120 published
Month from 1 Jan 2025: $6K published
Month from 1 Feb 2025: $25K published
Month from 1 Mar 2025: $13K published
Month from 1 May 2025: $25K published
Month from 1 Jun 2025: -$17K published
Month from 1 Jul 2025: $2K published
Month from 1 Sep 2025: $18K published
Month from 1 Oct 2025: $22K published
Month from 1 Mar 2026: $25K published
Month from 1 Apr 2026: -$897 published
Month from 1 Jun 2026: $0 published
Month from 1 Jul 2026: $0 published
Month from 1 Oct 2026: $27K published
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Apr 2022: $20K published
Quarter from 1 Jul 2022: $20K published
Quarter from 1 Oct 2022: $10K published

What is unusual now

  • Made public in the last 90 days: it had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year; it also had 864K shares sold short in the 30 Sep 2026 report, 3.5× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year Public on 27 Oct 2026.
  • Insider net buying (open market): Insiders bought a net $150K in the last 12 months (the 12 months before: $21K).
  • Revenue per quarter: Revenue $37.6M in the latest quarter, +3.0% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 12 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 May 2026Barry G SteeleExecutive VP and CFOBuy7,000$8.71$61KForm 4
12 May 2026Paul Andrew GendronDirectorBuy5,000$8.88$44KForm 4
12 May 2026Carrie LachancePresident and CEOBuy3,000$8.71$26KForm 4
2 Mar 2026Barry G SteeleExecutive VP and CFOBuy2,064$9.16$19KForm 4
22 Aug 2025Scott ShudaDirectorSell5,752$9.67$56KForm 4
28 May 2025Kenneth D. EichenbaumDirectorBuy2,000$5.18$10KForm 4
20 May 2025Ronald T HundzinskiDirectorBuy5,000$6.09$30KForm 4
19 May 2025Carrie LachancePresident and COOBuy3,132$6.07$19KForm 4

116 institutions reported shares at the end of Q3 2026, 77% of the shares outstanding; 26 opened a position, 10 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.1.6M7.87%$20.3M-8,488-0.5%
Minerva Advisors LLC1.4M6.81%$17.6M+15K+1.1%
American Century Companies Inc905K4.52%$11.7M+230K+34%
Vanguard Capital Management LLC799K3.99%$10.3M+8,048+1.0%
Punch & Associates Investment Management, Inc.772K3.85%$9.9M-63K-7.5%
Acadian Asset Management LLC752K3.75%+8,454+1.1%
Heartland Advisors Inc700K3.49%$9.0MNo change
First Eagle Investment Management, LLC628K3.13%$8.1M-612K-49%
Dimensional Fund Advisors LP608K3.03%$7.8M+8,672+1.4%
Renaissance Technologies LLC497K2.48%$6.4M-46K-8.5%

Company events

All 48 company events

In 12 months: 2 director or officer changes, 1 auditor change. Results releases and routine reports are left out.

FiledWhat happenedSource
14 May 2026Director or officer change8-K
12 May 2026Director or officer changeSame filing: shareholder vote results8-K
19 Mar 2026Changed its auditor8-K
17 Jul 2025Signed a major agreementSame filing: took on new debt8-K
3 Jun 2025Director or officer changeSame filing: changed shareholder rights, changed its bylaws or fiscal year8-K
20 May 2025Director or officer changeSame filing: shareholder vote results8-K
1 Apr 2025Director or officer change8-K
18 Nov 2024Director or officer change8-K

Reported lobbying spend: $10K in Q3 2022, $20K in Q2 2022. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Aug 2022EndedTiber Creek Groupfor Infusystems Holdings, Inc.Issues related to Medicare reimbursement for opioid alternative treatments, including H.R. 3259 & S. 586 - NOPAIN Act.Medicare/MedicaidFiling
11 Feb 2019NewTiber Creek Groupfor Infusystems Holdings, Inc.Access to non-opioid alternative treatments.Medicare/MedicaidFiling
1 Oct 2016EndedArnold & Porter Kaye Scholer LLPfor InfusystemNot statedFiling
1 Jan 2016EndedSquire Patton Boggsfor InfusystemNot statedFiling
15 Dec 2015NewArnold & Porter Kaye Scholer LLPfor InfusystemIssues regarding Medicare coverage of home infusion services.Medicare/MedicaidFiling
1 Jun 2015NewSquire Patton Boggsfor InfusystemIssues regarding Medicare coverage of home infusion services.Medicare/MedicaidFiling

The 5 newest of 17 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

26 Mar 2019confirmed

Confirmed across sources Insiders and Filings + Financials

InfuSystem (INFU): had 3 insiders buy $175K of its shares on the open market within 30 days (3 filings), while it reported revenue of $3.2M for the quarter ended 31 Dec 2018, 83% below the same quarter last year. Two unrelated kinds of activity within 4 days.

  • Insiders: Clustered insider buying, became public on 22 Mar 2019
  • Financials: Quarterly revenue change, became public on 26 Mar 2019
2016-09-30: $17.2M2017-03-31: $17.7M2017-06-30: $16.9M2017-09-30: $17.6M2017-12-31: $18.9M2018-03-31: $2.1M2018-06-30: $2.4M2018-09-30: $2.9M2018-12-31: $3.2M
The quarter ended 31 Dec 2018 against the 8 quarters before it. this quarterearliernormal: $17.1M
See the evidence (2 changes)

Insiders: Clustered insider buying became public on 22 Mar 2019

InfuSystem had 3 insiders buy $175K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$175K
Window
20 Feb 2019 to 22 Mar 2019
  • Dilorio Richard (President & CEO) bought 3,900 shares of INFU ($16,458)dated 13 Mar 2019, public 14 Mar 2019
  • Sansone Christopher R. (director) bought 25,000 shares of INFU ($109,000)dated 19 Mar 2019, public 20 Mar 2019
  • Shuda Scott (director) bought 11,224 shares of INFU ($49,065)dated 21 Mar 2019, public 22 Mar 2019

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Financials: Quarterly revenue change became public on 26 Mar 2019

InfuSystem reported revenue of $3.2M for the quarter ended 31 Dec 2018, 83% below the same quarter last year.

This period
$3.2M (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
$17.1M
Typical spread (median absolute deviation)
$1.2M
How far from its usual level
-7.9
Same quarter last year
$18.9M
History used
3,106 days
2016-09-30: $17.2M2017-03-31: $17.7M2017-06-30: $16.9M2017-09-30: $17.6M2017-12-31: $18.9M2018-03-31: $2.1M2018-06-30: $2.4M2018-09-30: $2.9M2018-12-31: $3.2M
the quarter ended 31 Dec 20188 earlier quartersnormal: $17.1M

Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 683K shares sold short in the 30 Oct 2026 report, 4.5× the same report last year.

    Same report last year: 153K; its normal report is 190K.

    See the evidence
    This period
    683K (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    190K
    Typical spread (median absolute deviation)
    49K
    How far from its usual level
    +6.8
    Same report last year
    153K
    History used
    3,227 days
    2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K2026-08-31: 755K2026-09-15: 812K2026-09-30: 864K2026-10-15: 813K2026-10-30: 683K
    the 30 Oct 2026 report24 earlier reportsnormal: 190K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 27 Oct 2026Short interest and volume change

    had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year.

    Same report last year: 146K; its normal report is 179K.

    See the evidence
    This period
    813K (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    179K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +12.1
    Same report last year
    146K
    History used
    3,212 days
    2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K2026-08-31: 755K2026-09-15: 812K2026-09-30: 864K2026-10-15: 813K
    the 15 Oct 2026 report24 earlier reportsnormal: 179K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2026Short interest and volume change

    had 864K shares sold short in the 30 Sep 2026 report, 3.5× the same report last year.

    Same report last year: 245K; its normal report is 179K.

    See the evidence
    This period
    864K (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    179K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +13.1
    Same report last year
    245K
    History used
    3,197 days
    2025-09-30: 245K2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K2026-08-31: 755K2026-09-15: 812K2026-09-30: 864K
    the 30 Sep 2026 report24 earlier reportsnormal: 179K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2026Short interest and volume change

    had 812K shares sold short in the 15 Sep 2026 report, 5.7× the same report last year.

    Same report last year: 143K; its normal report is 172K.

    See the evidence
    This period
    812K (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    172K
    Typical spread (median absolute deviation)
    36K
    How far from its usual level
    +12.0
    Same report last year
    143K
    History used
    3,182 days
    2025-09-15: 143K2025-09-30: 245K2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K2026-08-31: 755K2026-09-15: 812K
    the 15 Sep 2026 report24 earlier reportsnormal: 172K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Sep 2026Short interest and volume change

    had 755K shares sold short in the 31 Aug 2026 report, 4.6× the same report last year.

    Same report last year: 164K; its normal report is 169K.

    See the evidence
    This period
    755K (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    169K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +11.7
    Same report last year
    164K
    History used
    3,167 days
    2025-08-29: 164K2025-09-15: 143K2025-09-30: 245K2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K2026-08-31: 755K
    the 31 Aug 2026 report24 earlier reportsnormal: 169K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 26 Aug 2026Short interest and volume change

    had 734K shares sold short in the 14 Aug 2026 report, 4.6× the same report last year.

    Same report last year: 161K; its normal report is 165K.

    See the evidence
    This period
    734K (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    165K
    Typical spread (median absolute deviation)
    25K
    How far from its usual level
    +11.4
    Same report last year
    161K
    History used
    3,150 days
    2025-08-15: 161K2025-08-29: 164K2025-09-15: 143K2025-09-30: 245K2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K2026-08-14: 734K
    the 14 Aug 2026 report24 earlier reportsnormal: 165K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 12 Aug 2026Short interest and volume change

    had 781K shares sold short in the 31 Jul 2026 report, 5.5× the same report last year.

    Same report last year: 142K; its normal report is 162K.

    See the evidence
    This period
    781K (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    162K
    Typical spread (median absolute deviation)
    22K
    How far from its usual level
    +12.4
    Same report last year
    142K
    History used
    3,136 days
    2025-07-31: 142K2025-08-15: 161K2025-08-29: 164K2025-09-15: 143K2025-09-30: 245K2025-10-15: 146K2025-10-31: 153K2025-11-14: 186K2025-11-28: 154K2025-12-15: 147K2025-12-31: 194K2026-01-15: 172K2026-01-30: 119K2026-02-13: 136K2026-02-27: 111K2026-03-13: 171K2026-03-31: 216K2026-04-15: 213K2026-04-30: 212K2026-05-15: 154K2026-05-29: 166K2026-06-15: 136K2026-06-30: 894K2026-07-15: 815K2026-07-31: 781K
    the 31 Jul 2026 report24 earlier reportsnormal: 162K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 14 May 2026Filings record

    Director or officer change

  9. 13 May 2026Insiders change

    had 3 insiders buy $131K of its shares on the open market within 30 days (3 filings).

    Who bought: Steele Barry G, Gendron Paul Andrew, Lachance Carrie.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $131K
    Window
    13 Apr 2026 to 13 May 2026
    • Steele Barry G (Executive VP and CFO) bought 7,000 shares of INFU ($60,970)dated 12 May 2026, public 13 May 2026
    • GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($44,400)dated 12 May 2026, public 13 May 2026
    • Lachance Carrie (President and CEO) bought 3,000 shares of INFU ($26,120)dated 12 May 2026, public 13 May 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  10. 13 May 2026Insiders record

    Steele Barry G (Executive VP and CFO) bought 7,000 shares of INFU ($60,970) (dated 12 May 2026)

  11. 13 May 2026Insiders record

    GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($44,400) (dated 12 May 2026)

  12. 13 May 2026Insiders record

    Lachance Carrie (President and CEO) bought 3,000 shares of INFU ($26,120) (dated 12 May 2026)

  13. 12 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 12 May 2026Filings record

    Director or officer change

  15. 19 Mar 2026Filings record

    Changed its auditor

  16. 3 Mar 2026Insiders record

    Steele Barry G (Executive VP and CFO) bought 2,064 shares of INFU ($18,906) (dated 2 Mar 2026)

  17. 26 Jun 2025Short interest and volume change

    had 606K shares sold short in the 13 Jun 2025 report, 4.3× the same report last year.

    Same report last year: 142K; its normal report is 171K.

    See the evidence
    This period
    606K (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    171K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +8.7
    Same report last year
    142K
    History used
    2,723 days
    2024-06-14: 142K2024-06-28: 156K2024-07-15: 166K2024-07-31: 160K2024-08-15: 164K2024-08-30: 170K2024-09-13: 155K2024-09-30: 173K2024-10-15: 195K2024-10-31: 190K2024-11-15: 187K2024-11-29: 164K2024-12-13: 170K2024-12-31: 169K2025-01-15: 192K2025-01-31: 170K2025-02-14: 185K2025-02-28: 185K2025-03-14: 153K2025-03-31: 186K2025-04-15: 256K2025-04-30: 305K2025-05-15: 400K2025-05-30: 508K2025-06-13: 606K
    the 13 Jun 2025 report24 earlier reportsnormal: 171K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 11 Jun 2025Short interest and volume change

    had 508K shares sold short in the 30 May 2025 report, 3.6× the same report last year.

    Same report last year: 142K; its normal report is 170K.

    See the evidence
    This period
    508K (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    170K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +6.8
    Same report last year
    142K
    History used
    2,709 days
    2024-05-31: 142K2024-06-14: 142K2024-06-28: 156K2024-07-15: 166K2024-07-31: 160K2024-08-15: 164K2024-08-30: 170K2024-09-13: 155K2024-09-30: 173K2024-10-15: 195K2024-10-31: 190K2024-11-15: 187K2024-11-29: 164K2024-12-13: 170K2024-12-31: 169K2025-01-15: 192K2025-01-31: 170K2025-02-14: 185K2025-02-28: 185K2025-03-14: 153K2025-03-31: 186K2025-04-15: 256K2025-04-30: 305K2025-05-15: 400K2025-05-30: 508K
    the 30 May 2025 report24 earlier reportsnormal: 170K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 3 Jun 2025Filings record

    Director or officer change

  20. 29 May 2025Insiders record

    Eichenbaum Kenneth D. (director) bought 2,000 shares of INFU ($10,360) (dated 28 May 2025)

  21. 21 May 2025Insiders record

    Hundzinski Ronald T (director) bought 5,000 shares of INFU ($30,450) (dated 20 May 2025)

  22. 20 May 2025Filings record

    Director or officer change

  23. 20 May 2025Insiders record

    Lachance Carrie (President and COO) bought 3,132 shares of INFU ($19,000) (dated 19 May 2025)

  24. 15 May 2025Insiders record

    Steele Barry G (Executive VP and CFO) bought 3,000 shares of INFU ($17,280) (dated 14 May 2025)

  25. 1 Apr 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 1 Apr 2025Filings record

    Director or officer change

  27. 18 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 18 Nov 2024Filings record

    Director or officer change

  29. 26 Sep 2024Insiders record

    Eichenbaum Kenneth D. (director) bought 4,000 shares of INFU ($23,560) (dated 25 Sep 2024)

  30. 24 May 2024Insiders change

    had 6 insiders buy $123K of its shares on the open market within 30 days (6 filings).

    Who bought: Chupa Addam, Gendron Paul Andrew, Steele Barry G, Funke Jerod and 2 more.

    See the evidence (6 source records)
    Independent buyers
    6
    Purchase filings (Form 4, code P)
    6
    Total bought
    $123K
    Window
    24 Apr 2024 to 24 May 2024
    • Chupa Addam (Executive VP and CIO) bought 1,000 shares of INFU ($6,670)dated 21 May 2024, public 22 May 2024
    • GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($32,700)dated 21 May 2024, public 22 May 2024
    • Steele Barry G (Executive VP and CFO) bought 3,000 shares of INFU ($19,410)dated 21 May 2024, public 22 May 2024
    • Funke Jerod (EVP-Chief HR Officer) bought 1,000 shares of INFU ($6,390)dated 21 May 2024, public 22 May 2024
    • BOYD RALPH F JR (director) bought 4,000 shares of INFU ($28,520)dated 23 May 2024, public 24 May 2024
    • HUSS BEVERLY A (director) bought 4,300 shares of INFU ($29,498)dated 23 May 2024, public 24 May 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  31. 24 May 2024Insiders record

    BOYD RALPH F JR (director) bought 4,000 shares of INFU ($28,520) (dated 23 May 2024)

  32. 24 May 2024Insiders record

    HUSS BEVERLY A (director) bought 4,300 shares of INFU ($29,498) (dated 23 May 2024)

  33. 22 May 2024Insiders record

    Chupa Addam (Executive VP and CIO) bought 1,000 shares of INFU ($6,670) (dated 21 May 2024)

  34. 22 May 2024Insiders record

    GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($32,700) (dated 21 May 2024)

  35. 22 May 2024Insiders record

    Steele Barry G (Executive VP and CFO) bought 3,000 shares of INFU ($19,410) (dated 21 May 2024)

  36. 22 May 2024Insiders record

    Funke Jerod (EVP-Chief HR Officer) bought 1,000 shares of INFU ($6,390) (dated 21 May 2024)

  37. 3 Apr 2024Filings record

    Delisting notice or listing transfer

  38. 14 Mar 2024Filings record

    Report will be filed late

  39. 8 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 8 Mar 2024Filings record

    Director or officer change

Showing the newest 40 of 150 entries; narrow the window or the kind of data to see older ones.

Not listed: 158 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001337013
Ticker
INFU
Domain
infusystem.com
Hq location
MI|ROCHESTER HILLS|48309 (1 unverified)
Lobbying client
infusystem, infusystems holdings
Name
Document, EX-21.1, HAPC, Inc., Healthcare Acquisition Partners Corp. and 3 more
Uei
Q9FQBS8UMU64, QDSNXMCN6E75
  • Federal lobbying disclosures (LDA)6 records, 66 data points1 Jun 2015 to 30 Sep 2022
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)154 records21 Jan 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1064 data points31 Dec 2008 to 8 Nov 2026
  • SEC Form 4 insider transactions122 records, 416 data points6 Sep 2016 to 12 May 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4150 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards393 data points7 Jan 2009 to 7 Oct 2026